Perrigo Co. Tuesday announced that it has begun commercial shipments of betamethasone valerate foam 0.12%, the generic equivalent of Luxiq Foam, consistent with the date certain launch settlement previously announced.
Perrigo Co. (Nasdaq: PRGO) Tuesday announced that its partner, Cobrek Pharmaceuticals Inc., received final approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for betamethasone valerate foam 0.12 percent, the generic equivalent of Luxiq Foam.
- The Reunion Project – Friday Fun (5/17) May 17, 2013
- Trey Burke Talks Fab Five, Detroit Pistons With Ryan Wooley May 13, 2013
- Leach’s Lists: Three Keys For The Red Wings To Win Game 7 May 11, 2013
- Cedar Point’s GateKeeper Is A Real Crowd Pleaser May 11, 2013